TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Merck Life Science Oy
Closing information (x1000 DKK)
Closing information | 2016/12 | 2015/12 | 2014/12 |
Turnover |
61,356
|
57,877
|
40,777 |
Financial expenses |
7
![]() |
7
|
30 |
Earnings before taxes |
1,859
|
1,358
|
2,315 |
Total assets |
15,464
|
13,902
|
12,835 |
Current assets |
201
|
187
|
462 |
Current liabilities |
5,301
|
5,186
|
5,212 |
Equity capital |
10,155
|
8,708
|
7,616 |
- share capital |
1,041
|
1,045
|
1,042 |
Employees (average) | 8 | 7 |
Financial ratios
Fiscal year | 2016/12 | 2015/12 | 2014/12 |
Solvency |
65.7%
|
62.6%
|
59.3% |
Turnover per employee | 7,670 | 5,825 | |
Profit as a percentage of turnover |
3.0%
|
2.3%
|
5.7% |
Return on assets (ROA) |
12.1%
|
9.8%
|
18.3% |
Current ratio |
3.8%
|
3.6%
|
8.9% |
Return on equity (ROE) |
18.3%
|
15.6%
|
30.4% |
Change turnover |
3,695
|
17,006
|
1,966 |
Change turnover % |
6%
|
42%
|
5% |
Chg. No. of employees | -1 | ||
Chg. No. of employees % | -13% |
Total value of public sale
Fiscal year | 2016/12 | 2015/12 | 2014/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.